Симуляция графика K-линий, фактические данные указаны на торговой странице
Ключевые данные
Открытие вчера
--
Пред. закрытие
--
Вчерашний диапазон
--
Диапазон 52 нед.
--
Объем торговли
--
МС
--
P/E
--
EPS
--
Обзор компании
PAVmed Inc. is a medical device company in the United States. The company is headquartered in New York, New York.
СекторHEALTHCARE
ОтрасльMEDICAL DEVICES
Штаб-квартира360 MADISON AVENUE, NEW YORK, NY, UNITED STATES, 10017
СтранаUSA
Дата листинга--
Конец финансового года--
Акции в обращении--
Код CIK--
Официальный сайт--
Финансовые показатели
Индикатор
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Доход
$33K
$22K
$52K
$5K
Операционные расходы
$122K
$117K
$103K
$55K
Чистая прибыль
-$5.384M
-$60K
-$1.263M
-$5.383M
Чистая рентабельность
-16315.2%
-272.7%
-2428.8%
-107660.0%
Прибыль на акцию
--
$-0.04
$-1.63
$-7.49
EBITDA
-$6.596M
-$1.041M
-$2.734M
-$5.981M
Эффективная налоговая ставка
--
-556766.9%
--
-5273.7%
Часто задаваемые вопросы
PAVmed Inc. is a diversified medical technology company specializing in innovative healthcare solutions. Its portfolio focuses on diagnostics, medical devices, and digital health technologies aimed at improving patient outcomes and addressing unmet needs in the sector.
PAVmed Inc. operates within the healthcare sector and specifically in the medical devices and diagnostics industry. This sector focuses on developing technologies to diagnose, monitor, and treat health conditions efficiently.
PAVmed Inc.'s revenue growth is primarily driven by the commercialization of its diagnostic platforms, such as EsoGuard and the broader portfolio of medical technologies. Expanding market adoption and integration into healthcare systems contribute significantly to its financial performance.
PAVmed Inc. faces competition from other medical technology companies focused on diagnostics and medical devices, including industry leaders such as Medtronic, Boston Scientific, and more specialized firms offering similar products or solutions.
No, PAVmed Inc. does not currently pay dividends to shareholders. The company appears to focus on reinvesting in research and development to grow its product portfolio and advance its long-term strategic initiatives.
Investing in PAVmed Inc. involves risks such as regulatory challenges, the competitive landscape in the healthcare technology sector, potential delays in product commercialization, and overall market volatility. Investors should carefully consider these risks alongside the company’s growth initiatives.
PAVmed Inc. has opportunities tied to the expanding demand for advanced diagnostic tools and innovative medical devices. Its focus on addressing unmet needs and its diverse portfolio provide potential for revenue growth and increased market share.
Investors can monitor PAVmed Inc.'s financial performance by reviewing its quarterly earnings reports, SEC filings, and key metrics such as revenue growth, product commercialization updates, and cash flow figures. Staying informed about industry trends is also essential.
Предупреждение о рисках
1.Цены на акции могут сильно колебаться, инвестируйте осторожно. Прошлые результаты не гарантируют будущую доходность.
2.Торговля цифровыми активами сопряжена с рыночными, техническими и иными рисками. Пожалуйста, принимайте взвешенные решения и рационально распределяйте активы.
3.Информация на этой странице предназначена только для ознакомления и не является инвестиционной рекомендацией.